CalciMedica Statistics
Total Valuation
CalciMedica has a market cap or net worth of $46.47 million. The enterprise value is $31.87 million.
| Market Cap | 46.47M |
| Enterprise Value | 31.87M |
Important Dates
The last earnings date was Wednesday, November 13, 2024, before market open.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CalciMedica has 13.47 million shares outstanding. The number of shares has increased by 61.49% in one year.
| Current Share Class | 13.47M |
| Shares Outstanding | 13.47M |
| Shares Change (YoY) | +61.49% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 11.77% |
| Owned by Institutions (%) | 13.75% |
| Float | 6.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.11 |
| P/TBV Ratio | 5.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.15
| Current Ratio | 4.15 |
| Quick Ratio | 3.86 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -55.92 |
Financial Efficiency
Return on equity (ROE) is -128.26% and return on invested capital (ROIC) is -36.29%.
| Return on Equity (ROE) | -128.26% |
| Return on Assets (ROA) | -23.98% |
| Return on Capital (ROIC) | -36.29% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.13M |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.86% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -0.86% |
| 50-Day Moving Average | 3.97 |
| 200-Day Moving Average | 4.50 |
| Relative Strength Index (RSI) | 42.37 |
| Average Volume (20 Days) | 95,891 |
Short Selling Information
The latest short interest is 72,576, so 0.54% of the outstanding shares have been sold short.
| Short Interest | 72,576 |
| Short Previous Month | 34,158 |
| Short % of Shares Out | 0.54% |
| Short % of Float | 1.04% |
| Short Ratio (days to cover) | 1.68 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.15M |
| Pretax Income | -14.94M |
| Net Income | -13.59M |
| EBITDA | -6.09M |
| EBIT | -6.15M |
| Earnings Per Share (EPS) | -$1.44 |
Balance Sheet
| Cash & Cash Equivalents | 14.60M |
| Total Debt | n/a |
| Net Cash | 14.60M |
| Net Cash Per Share | $1.08 |
| Equity (Book Value) | 9.03M |
| Book Value Per Share | 0.84 |
| Working Capital | 11.90M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CalciMedica does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -61.49% |
| Shareholder Yield | -61.49% |
| Earnings Yield | -29.24% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for CalciMedica is $19.50, which is 465.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.50 |
| Price Target Difference | 465.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |